MedChem 2017

The Many Pharmacotherapeutic Faces of Nucleosides and Oligonucleotides

Annual One-Day Meeting on Medicinal Chemistry of KVCV & SRC

 Leuven, Belgium    December 1, 2017

Programme


08:00

Registration

08:50

Opening

Prof Piet HERDEWIJN
KU LEUVEN, Leuven, Belgium

09:00

PL01 - 2’-Spiro-substituted Nucleosides Active against the Hepatitis C-virus

Dr Tim JONCKERS
JANSSEN, Beerse, Belgium

09:50

PL02 - Use of Cyclic Dinucleotides (CDNs) to Induce Stimulator of Interferon Genes (STING)-Dependent Antitumor Immunity

Dr Cedric BOULARAN
INVIVOGEN, Toulouse, France

10:40

Coffee break and Exhibition

11:15

OC01 - Unlock your Compound Management

Dr Jan BREITENFELD
CHEMSPEED TECHNOLOGIES AG, Füllinsdorf, Switzerland

11:35

PL03 - Discovery of Novel DOT1L Inhibitors by Fragment Growing, Defragmentation and Fragment Linking

Dr Henrik MOEBITZ
NOVARTIS, Basel, Switzerland

12:25

Lunch, Exhibition and Poster session

14:00

PL04 - Antitumoral and Antiviral Nucleosides, siRNAs and shRNAs for Applications in vitro, in vivo and in Bioprinted 3D Organ Models

Prof. Jens KURRECK
UNIVERSITY OF BERLIN, Berlin, Germany

14:50

OC02 - Novel 3'-Deoxy Purine Nucleoside Analogs as Highly Potent Leads for Human African Trypanosomiasis

Mr Fabian HULPIA
UGENT, Ghent, Belgium

15:10

OC03 - New Genetic Systems with Four Non-Canonical Nucleobases: Biotechnology and Therapeutic Applications

Dr Elena EREMEEVA
KU LEUVEN, Leuven, Belgium

15:30

Coffee break, Exhibition and Poster session

16:05

PL05 - Synthetic Genetics: Beyond DNA and RNA

Dr Philipp HOLLIGER
MRC LABORATORY OF MOLECULAR BIOLOGY, Cambridge, United Kingdom

16:55

PL06 - Large Scale Pooled Crispr Screening: Mining for the Deep

Dr Roderick BEIJERSBERGEN
NETHERLANDS CANCER INSTITUTE, Amsterdam, The Netherlands

17:45

Closing Remarks